T. Demirer Et Al. , "High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors," BONE MARROW TRANSPLANTATION , vol.27, 2001
Demirer, T. Et Al. 2001. High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors. BONE MARROW TRANSPLANTATION , vol.27 .
Demirer, T., Ilhan, O., Ayli, M., Arat, M., Fen, T., Ozcan, M., ... Arslan, O.(2001). High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors. BONE MARROW TRANSPLANTATION , vol.27.
Demirer, TANER Et Al. "High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors," BONE MARROW TRANSPLANTATION , vol.27, 2001
Demirer, TANER Et Al. "High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors." BONE MARROW TRANSPLANTATION , vol.27, 2001
Demirer, T. Et Al. (2001) . "High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors." BONE MARROW TRANSPLANTATION , vol.27.
@article{article, author={TANER DEMİRER Et Al. }, title={High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors}, journal={BONE MARROW TRANSPLANTATION}, year=2001}